In this first chapter, we introduce the central concepts of this handbook: addiction, recovery
and quality of life. Addiction and Substance use disorders (SUDs) present a significant …

INTRODUCTION The opioid crisis represents one of the most devastating public health
events in modern US history. Although the genesis of the opioid crisis can be traced to the …

With more than 290 million surgical procedures performed globally each year, 1
management of postoperative pain is an important health care priority. While opioids are an …

In this issue of Anesthesia & Analgesia, there are 3 articles1–3 in a special series on
substance use disorders (SUDs) and their relevance to the preoperative care of patients …

This paper explores the rapid emergence of xylazine exposure in the USA and its
implications for anesthesiologists. Xylazine, a non-opioid sedative and analgesic often used …

Buprenorphine and naloxone (buprenorphine-naloxone) combination is Food and Drug
Administration (FDA)–approved for detoxification from opioids and maintenance therapy for …

Background Affecting> 20million people in the US, including 4% of all hospitalized patients,
substance use disorder (SUD) represents a growing public health crisis. Evaluating a …

For years, anesthesiologists have included ques-tions about illicit or street drugs, alcohol,
and herbal supplement use in addition to conventional questions about prescription …

Substance use disorders (SUDs) are considered a major public health concern in the United
States and their incidence is increasing at an alarming rate. Anesthesiologists may …

This chapter focuses on the pharmacological interactions between opioids or psychoactive
substances, such as cocaine, amphetamines, products containing tetrahydrocannabinol and …